Products

What will AGI do for Benzarone?

This classification denotes a thrombolytic agent with the molecular formula C17H14O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 23ZW4BG89C, chemically known as methanone, (2-ethyl-3-benzofuranyl)(4-hydroxyphenyl)- but generally known as benzarone, which bears US NIH Compound Identifier 255968. European Medicines Agency schedules Benzarone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05740MIG. The term BENZARONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). BENZARONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzarone under HS 29329985 and SITC 51569. As of Q4 2014, BENZARONE remains the US FDA Preferred Term for this commodity. Benzarone bears US NLM identifiers UMLS ID C0053152 and NCI Concept Code C74411. SMILES: O1C(C(C2C1CCCC2)C(=O)C1CCC(O)CC1)CC.

How AGI delivers it

Four ways AGI delivers for Benzarone

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Benzarone, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Benzarone, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Benzarone connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Loss On Dryingmodel
  • Melting Pointmodel